Latest Regulatory Approvals News

EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.

Greatland Resources posted a robust half-year profit of $342.9 million, driven by full ownership of the Telfer mine and a strong operational ramp-up. The Havieron feasibility study confirms a world-class gold-copper project, setting the stage for future growth.

QMines Limited has significantly upgraded its Develin Creek Mineral Resource, increasing Indicated Resources by 46% and total resources by 14%, setting the stage for Phase 2 development planning.

Minerals 260 has locked in a $220 million strategic funding deal with Franco-Nevada, boosting development and de-risking the Bullabulling Gold Project in Western Australia. This marks Franco-Nevada’s largest Australian investment to date.

Nuix Limited has reported robust half-year results for 1H26, highlighted by a 148% increase in Nuix Neo Annualised Contract Value and a significant boost in profitability and cash flow.

Stanmore Resources delivered record coal production and strong cash flow in 2025 despite softer market prices, declaring a fully franked dividend and guiding a modest production decline for 2026.

Osmond Resources has partnered with Técnicas Reunidas to establish the European Union’s first vertically integrated rare earth production facility, aiming to reduce reliance on imports and boost local supply chains.

Hartshead Resources has updated the schedule for its proposed acquisition by ACAM GP Limited, with key shareholder and court dates set through May 2026. The revised timetable outlines the next steps in the scheme of arrangement process.

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.

Recharge Metals Limited has inked a binding deal to acquire the Sunset Well Gold Project in Western Australia's Leonora district, featuring a 94,500-ounce inferred gold resource. The company has also secured $5.75 million in capital to kickstart drilling and exploration activities.

Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.